NCT00612950View on ClinicalTrials.gov

Beta-Cell Function After Near-Normalisation of Blood Glucose

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

February 28, 2007

Study Completion Date

May 31, 2007

Conditions
Type 2 Diabetes
Interventions
DRUG

glucagon-like peptide-1,

GLP-1:continuous infusion of ½ pmol/kg/min for a total time of 120 minutes.

DRUG

glucose dependent insulinotropic polypeptide

continuous infusion of GIP (1½ pmol/kg/min) for 120 min.

DRUG

Saline

continuous infusion of Saline for 120 min

Trial Locations (1)

Unknown

Dept. of Endocrinology, Hvidovre Hospital, Copenhagen

All Listed Sponsors
lead

Hvidovre University Hospital

OTHER

NCT00612950 - Beta-Cell Function After Near-Normalisation of Blood Glucose | Biotech Hunter | Biotech Hunter